Ignite Creation Date:
2024-05-06 @ 10:25 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03258034
Status:
UNKNOWN
Last Update Posted:
2017-08-22
First Post:
2017-08-20
Brief Title:
A Feasibility Study for Convernsion Therapy Using S1Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer
Sponsor:
The First Affiliated Hospital of Zhejiang Chinese Medical University
Organization:
The First Affiliated Hospital of Zhejiang Chinese Medical University
Organization Data
Organization:
The First Affiliated Hospital of Zhejiang Chinese Medical University
Class:
OTHER
Study ID:
Ahead-G328
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Fujian Cancer Hospital | OTHER_GOV |
| Zhejiang Cancer Hospital | OTHER |